Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Three Testosterone Gel Formulations in Postmenopausal Women

The primary objective is to evaluate the pharmacokinetic profile and safety of three different testosterone gel formulations in postmenopausal female participants. Determining these parameters is essential for establishing the absorption, distribution, metabolism, and excretion characteristics of the topical administration. There are no secondary objectives reported.

The sponsor did not provide information regarding the total number of participants. The study population consists of healthy volunteers. The cohort is limited to females within age ranges 3 and 4. No medical conditions are reported for this group.

This Phase 1 clinical trial is designed to investigate the pharmacokinetic profile and safety of three different testosterone gel formulations in postmenopausal female participants. The study employs a controlled research methodology to evaluate the absorption and metabolic characteristics of the investigational products. The protocol commences with a screening visit to determine eligibility. Subsequent study visits are conducted to monitor physiological responses and collect data according to the predefined schedule. The trial concludes with an end-of-study visit. Participant involvement is subject to adherence to the protocol, and early termination may occur if specific safety criteria or withdrawal conditions are met.

The assessment of efficacy in this Phase 3 clinical trial is not specified in the provided documentation.